Home pageBCRX • NASDAQ
add
BioCryst Pharmaceuticals
8,69 $
After Hours:(0,00%)0,00
8,69 $
Data e ora chiusura: 3 mar, 17:42:54 GMT-5 · USD · NASDAQ · Disclaimer
Chiusura precedente
8,63 $
Intervallo giornaliero
8,45 $ - 8,86 $
Intervallo annuale
6,00 $ - 11,31 $
Cap di mercato
2,18 Mld USD
Volume medio
4,59 Mln
Rapporto P/E
7,20
Dividendo/Prezzo
-
Borsa valori principale
NASDAQ
Notizie
Informazioni
BioCryst Pharmaceuticals, Inc. is an American pharmaceutical company headquartered in Durham, North Carolina. The company is a late stage biotech company that focuses on oral drugs for rare and serious diseases. BioCryst's antiviral drug peramivir was approved by FDA in December 2014. It has also been approved in Japan, Korea, and China. Wikipedia
Fondazione
1986
Sito web
Dipendenti
435
